Medicare Enrolled

Dr. Edwin Villalobos, M.D.

Physical Medicine & Rehabilitation · Lake Mary, FL
Low-engagement
2692 W LAKE MARY BLVD, Lake Mary, FL 32746
3217108027
In practice since 2006 (19 years)
NPI: 1861572653 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Villalobos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Villalobos? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Villalobos

Dr. Edwin Villalobos is a physical medicine & rehabilitation in Lake Mary, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Villalobos received a total of $3,593 from 31 pharmaceutical and/or device companies across 257 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physical medicine & rehabilitation. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Villalobos is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $3,593 industry payments

Industry Payment Transparency

Open Payments through 2020 ↗
$3,593
Total received (2018-2020)
Avg $1,198/year across 3 years
Top 18% in FL for physical medicine & rehabilitation
31
Companies
257
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,593 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2020
$243
2019
$1,434
2018
$1,917

Payments by company (2020)

Consulting
Speaking
Meals & Travel
Research
Medtronic USA, Inc.
$734
Collegium Pharmaceutical, Inc.
$374
Daiichi Sankyo Inc.
$308
Nevro Corp.
$277
Allergan Inc.
$221
Flowonix Medical Incorporated
$176
Electronic Waveform Lab, Inc.
$152
Boston Scientific Corporation
$134
Stimwave Technologies Incorporated
$111
PFIZER INC.
$110
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$99
Teva Pharmaceuticals USA, Inc.
$94
SI-BONE, Inc.
$94
Amgen Inc.
$90
Scilex Pharmaceuticals Inc.
$73
Lilly USA, LLC
$70
ARBOR PHARMACEUTICALS, INC.
$60
Kaleo, Inc.
$53
BioDelivery Sciences International, Inc.
$50
US WorldMeds, LLC
$41
SCILEX PHARMACEUTICALS INC.
$35
Bausch Health US, LLC
$33
Novartis Pharmaceuticals Corporation
$32
AstraZeneca Pharmaceuticals LP
$31
Bioventus LLC
$30
Shionogi Inc
$27
West Therapeutics Development, LLC
$22
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$20
Assertio Therapeutics, Inc.
$15
Arbor Pharmaceuticals, Inc.
$13
Purdue Pharma L.P.
$12
Top 3 companies account for 39.4% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Accurian · Aimovig · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Cambia · Durolane · EMGALITY · Evzio · Horizant · INTELLIS · LYRICA · Lazanda · Lucemyra/Lofexidine · MIGRANAL · MOVANTIK · Morphabond ER · Prometra II · RELISTOR · RELISTOR ORAL · RESTORE · SPECTRA WAVEWRITER · SYMPROIC · SYNCHROMED · Senza Spinal Cord Stimulation System · Symproic · XTAMPZA · XTAMPZAER · Xtampza ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a physical medicine & rehabilitation in Lake Mary?
Compare physical medicine & rehabilitations in the Lake Mary area by procedure volume, costs, and industry payment transparency.
Browse physical medicine & rehabilitations nearby

Geographic Context

Physical Medicine & Rehabilitations within 10 mi
91
Per 100K population
19.2
County median income
$83,030
Nearest hospital
CENTRAL FLORIDA LAKE MONROE HOSPITAL
3.7 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2020
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Villalobos is a physical medicine & rehabilitation, and high industry engagement (low-engagement, top 18%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Villalobos receive payments from pharmaceutical companies?
Yes. Dr. Villalobos received a total of $3,593 from 31 companies across 257 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Villalobos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Physical Medicine & Rehabilitation
Common procedures, typical costs, and what industry payments mean in physical medicine & rehabilitation.
Same specialty & city
Physical Medicine & Rehabilitations in Lake Mary
Browse physical medicine & rehabilitations in Lake Mary ranked by procedure volume and transparency data.
Highest volume
Top Physical Medicine & Rehabilitations in FL
Physical Medicine & Rehabilitations ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Physical Medicine & Rehabilitations in FL
Which FL physical medicine & rehabilitations receive the most from drug and device companies.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc..
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc..
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →